Madrigal Pharmaceuticals
MDGL
MDGL
267 hedge funds and large institutions have $5.64B invested in Madrigal Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 75 funds opening new positions, 86 increasing their positions, 79 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
267
Holders Change
+41
Holders Change %
+18.14%
% of All Funds
3.87%
Holding in Top 10
14
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.2%
New
75
Increased
86
Reduced
79
Closed
33
Calls
$372M
Puts
$376M
Net Calls
-$4.8M
Net Calls Change
-$150M
Top Buyers
| 1 |
PC
Paulson & Co
New York
|
$474M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
$214M |
| 3 |
PA
Perceptive Advisors
New York
|
$115M |
| 4 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
$33.4M |
| 5 |
AC
Armistice Capital
New York
|
$44.9M |
Top Sellers
| 1 |
GAM
Groupama Asset Management
Paris,
France
|
$3.02M |
| 2 |
RI
RTW Investments
New York
|
$106M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
$7.45M |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
$695M |
| 5 |
Jane Street
New York
|
$6.72M |
